| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,931 |
8,304 |
$608K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,980 |
2,694 |
$320K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,475 |
1,473 |
$137K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,003 |
1,000 |
$103K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,002 |
1,970 |
$100K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
713 |
687 |
$96K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,072 |
1,052 |
$91K |
| 81007 |
|
2,745 |
2,564 |
$72K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
466 |
460 |
$63K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
447 |
447 |
$41K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
434 |
432 |
$40K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,055 |
1,005 |
$39K |
| 92551 |
|
3,838 |
3,799 |
$38K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,922 |
1,912 |
$35K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,843 |
1,800 |
$27K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
186 |
186 |
$27K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
621 |
592 |
$25K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
192 |
183 |
$9K |
| 99215 |
Prolong outpt/office vis |
55 |
55 |
$8K |
| 94060 |
|
155 |
147 |
$5K |
| 99205 |
Prolong outpt/office vis |
15 |
15 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
29 |
29 |
$2K |
| 94010 |
|
51 |
49 |
$2K |
| 86318 |
|
89 |
84 |
$1K |
| 99442 |
|
52 |
50 |
$1K |
| 99443 |
|
13 |
13 |
$462.76 |
| 90686 |
|
864 |
861 |
$1.00 |
| 90651 |
|
225 |
225 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |
| 90734 |
|
203 |
203 |
$0.00 |
| 90707 |
|
25 |
25 |
$0.00 |
| 90715 |
|
38 |
38 |
$0.00 |
| 90670 |
|
39 |
39 |
$0.00 |
| 90710 |
|
13 |
13 |
$0.00 |